Main Article Content


Analysis of the frequency of distribution of alleles and genotypes of polymorphism of the TP53 rs 17884159 gene depending on the severity of the disease at the time of the study showed negative associations, consisting in a significant increase in the prevalence of carriage of the heterozygous C/T genotype associated with the severity of CIN: carriage of the heterozygous C/T genotype increases the risk of pathology in LSIL 1.947 times; HSIL CIN ΙΙ - 3.957 times and HSIL CIN ΙΙΙ - 2.250 times. In our studies, the carriage of unfavorable C/T and T/T genotypes is associated with an increase in the severity of CIN


cervical intraepithelial neoplasia (CIN) human papillomavirus (HPV) viruses oncosupressor TP53 rs 17884159 heterozygous C/T genotype C/T and T/T genotypes

Article Details

How to Cite
I.A, K. (2021). The role of the genetic polymorphism of the gene - oncosupressor TP53 rs 17884159 in women with cervical intraepithelial neoplasia. Central Asian Journal of Medical and Natural Science, 2(3), 31-36.


  1. 1. Vinogradov A.V., Rezaikin A.V., Sergeev A.G. Prognostic value of the TP53 gene mutation in the programmed treatment of patients with acute leukemia // Bulletin of the Russian Oncological Research Center im. N.N.Blokhin, RAMS, vol. 24, no. 2, 2013. – pp. 33–41.
  2. 2. Voropaeva E.N., Pospelova T.I., Voevoda M.I., Marinkin I.O., Maksimov V.N., Ageeva T.A., Berezina O.V., Kolesnikova M.A. Allelic imbalance in the TP53 gene in patients with diffuse large cell lymphoma - carriers of RS783782222 // Siberian Medical Journal. - 2017, Volume 32, No. 2. - P.18-22.
  3. 3. Dianova D.G. Scientific bases of hygienic analysis of the regularities of the influence of haptens supplied with drinking water on the immune system in children: Author's abstract. dis. ... Doctor of Medical Sciences Perm, 2019. - 48p.
  4. 4. Dolgikh OV Methodological approaches to identifying the features of genetic polymorphism as markers of early disorders of immune regulation under conditions of chronic exposure to strontium / O.V.Dolgikh, N.V. Zaitseva, A.V.Krivtsov, D.G.Dianova, N.V.Bezruchenko, M.A.Guselnikov // Russian Journal of Immunology. - 2017. - T 11 (20), No. 3. - P. 369–371.
  5. 5. Ershov, V.A. Reproduction of human papillomavirus genotype 16 and integration of viral DNA in the altered cervical epithelium / V.A. Ershov [et al.] // Oncology. Journal. them. P. A. Herzen. - 2013. - No. 1. - P. 21–26
  6. 6. Zabela A.V., Sumenkova D.V. Molecular genetic changes in the process of apoptosis in neoplastic processes // innovative science medical sciences - No. 5-2 / 2018.- P.116-125.
  7. 7. Ibragimova M.K., Tsyganov M.M., Karabut I.V., Churuksaeva O.N., Shpileva O.N., Bychkov V.A., Kolomiets L.A., Litvyakov N.V. Integrative and episomal forms of genotype 16 of human papillomavirus in cervical intraepithelial neoplasia and cervical cancer. Virology issues. 2016; 61 (6): 270-274. DOI:
  8. 8. Kiseleva T.S. Persistence of human papillomavirus in the cervix and allelic polymorphism of genes of toll-like receptors, interferon lambda / T.S. Kiseleva, O. P. Gumilevskaya, U.B. Matokhina, K.P. Vakhania // Bulletin of Volgograd State Medical University. - 2017. - No. 3. - T.63. - P. 56-59.
  9. 9. Kobaidze E.K. Individualization of treatment tactics in patients with chronic endometritis on the basis of a comprehensive study of clinical and anamnestic, microbiological, immunological and genetic factors: Author's abstract. dis. ... MD Volgograd, 2019. - 48p.
  10. 10. Kotikovich Y.S. The reason for the development of cancer is a mutation of the tumor suppressor protein // Physician-Practitioner, Editorial Office of the Ukrainian Medical Journal. - 2019-03-25 p.:
  11. 11. Muskhadzhieva L. E., Margoshvili M. T., Zandukaeva M. R., Bisultanova Z. I., Dzhambetova P. M. The role of tumor suppressor genes P53 and CHEK2 in the development of breast tumor // scientific community of students XXI centuries. Natural Sciences. Electronic collection of articles based on the materials of the LIX student international scientific and practical conference, December 2017.- № 12 (58). - Novosibirsk, 2017.- P.15 - 20.
  12. 12. Sidorova I.S., Unanyan A.L., Drukh V.M., Muizhnek E.L. Effect of a new pharmaceutical composition containing epigallocatechin-3-gallate on methylation of tumor suppressor genes in patients with cervical intraepithelial neoplasia. RUDN Bulletin. - 2014. - No. 3. - P. 82-87.
  13. 13. Khunova L.Z. Qualitative assessment of molecular biological factors of early carcinogenesis of the cervix: Author's abstract. dis. Ph.D., Moscow, 2012. -- 22 p.
  14. 14. Chernova V.F. Clinical, morphological and molecular criteria of HPV-associated diseases of the cervix in women of different ages: author. dis. ... Ph.D., Moscow, 2018. - 28p.
  15. 15. Schepotin І.B., Zotov O.S., Lyubota R.V., Anikusko M.F., Lyubota І.І. Clinical significance of p53 mutations in breast cancer (literature review) №8 (4) 2012:
  16. 16. Choi S., Chen M., Cryns V.L. (2019) A nuclear phosphoinositide kinase complex regulates p53. Nature Cell Biology. – 2019. - Mar. 18. DOI: 10.1038/s41556-019-0297-2.
  17. 17. Ebisch R.M., Siebers A.G., Bosgraaf R.P., et al. Triage of high-risk HPV positive women in cervical cancer screening. Expert Rev Anticancer Ther. 2016; 16 (10): 1073–85.
  18. 18. Gorobtsova V.V., Kovalev A.A. Cervical cancer: the urgency of the problem, the principles of treatment. Glavniy vrach Yuga Rossii [Chief Physician of the South of Russia]. 2016; 1 (48): 63–6. (in Russian).
  19. 19. Kogan Е.A., Unanyan A.L., Kadyrova A.E., Sidorova I.S., Ischenko A.I. Immunohistochemical Analysis of Epigenetic Markers in Cervical Pathologies Associated with Human Papillomavirus Infection // BioNanoScience. – 2016. - 1–4, doi: 10.1007/s12668-016-0339-1
  20. 20. Luttmer R., De Strooper L.M., Steenbergen R.D., et al. Management of high-risk HPV-positive women for detection of cervical (pre)cancer. Expert Rev Mol Diagn. 2016; 16(9): 961–74.
  21. 21. Prives C., Lowe S. W. Cancer: Mutant p53 and chromatin regulation // Nature. 2015. V. 525. P. 199–200.
  22. 22. Zhu J. et al. Gain-of-function p53 mutants co-opt chromatin pathways to drive cancer growth // Nature. 2015. V. 525. P. 206–211. – 2014. – Vol.58. – № 9. – P.5111–5116.